Description: Torque’s Montor BL Tablets contain Bilastine, a second-generation H1-antihistamine and Montelukast which is a leukotriene receptor antagonist. Pharmaceutical Dosage Form: Tablets Route of Administration: Oral Composition:
| Each film coated tablet contains: | ||
| Bilastine | IP | 20 mg |
| Montelukast sodium eq. to Montelukast | IP | 10 mg |
| Excipients | q.s. | |
Mechanism of Action: Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H1 receptor antagonist affinity and no affinity for muscarinic receptors. Montelukast is an orally active compound that binds with high affinity and selectivity to the CysLT1 receptor. CysLT (cysteinyl leukotriene: LTC4, LTD4, LTE4) receptors have been correlated with the pathophysiology of asthma and allergic rhinitis Indications: Torque’s Montor BL Tablets are indicated for the treatment of allergic rhinitis (Perennial and Seasonal). Dosage: As directed by the physician. Storage: Store at a temperature not exceeding 30°C, protect from light & moisture Presentation: 10 x 1 x 10 Tablets Side effects: Headache Allergic conjunctivitis Abdominal pain/upper abdominal pain Drowsiness Contraindications: Torque’s Montor BL Tablets are contraindicated in patients with known hypersensitivity to the active substance or to any of the excipients. Drug Interaction: Ketoconazole or Erythromycin Diltiazem Lorazepam Theophylline Prednisolone Terfenadine Digoxin Warfarin